Travere Therapeutics, Inc. (TVTX) has 96 open-market insider trades by 10 insiders since 2020. Over the last six months insiders net sold $144K. The most active filer is Eric M. Dube, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steve Aselage | Dir | — | 11 | $5.4M | 2022-05-11 |
| Eric M. Dube | CEO | — | 17 | $4.8M | 2026-09-17 |
| Peter Heerma | CCOVP | — | 15 | $1.4M | 2026-09-17 |
| Elizabeth E. Reed | CLO | — | 10 | $1.3M | 2026-09-15 |
| Christopher R. Cline | CFO | — | 16 | $681K | 2026-09-15 |
| Sandra Calvin | CAOVP | — | 10 | $618K | 2026-09-15 |
| Laura Clague | CFO | — | 6 | $572K | 2022-05-11 |
| William E. Rote | — | — | 6 | $441K | 2026-09-16 |
| Jula Inrig | CMOVP | — | 4 | $388K | 2026-09-15 |
| Noah L. Rosenberg | Chief Medical Officer | — | 1 | $24K | 2021-08-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William E. Rote | — | Sell | $13.1M | 2026-09-15 |
| Peter Heerma | CCO & VP | Sell | $17.9M | 2026-09-15 |
| Jula Inrig | CMO & VP | Sell | $2.8M | 2026-09-15 |
| Sandra Calvin | CAO & VP | Sell | $335K | 2026-09-15 |
| Eric M. Dube | CEO | Sell | $25.4M | 2026-09-15 |
| Elizabeth E. Reed | CLO | Sell | $2.3M | 2026-09-15 |
Companies that share insiders with TVTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Christopher R. Cline | CFO | Sell | $3.1M | 2026-09-15 |
| Jeffrey A. Meckler | Director | Sell | $1.3M | 2026-09-10 |
| Christopher R. Cline | CFO | Sell | $43K | 2026-09-02 |
| Gary A. Lyons | Director | Sell | $633K | 2026-08-17 |
| Roy D. Baynes | Director | Sell | $225K | 2026-06-12 |
| Timothy Coughlin | Director | Sell | $501K | 2026-06-12 |
| Timothy Coughlin | Director | Sell | $141K | 2026-05-15 |
| William E. Rote | — | Sell | $121K | 2026-05-06 |
| Eric M. Dube | CEO | Sell | $989K | 2026-05-06 |